title: Neuroprotective effects of E-PodoFavalin-15999 (Atremorine®).
authors.affiliation: Departamento de Toxicología y Farmacología, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Romero
authors.affiliation: Molecular Neuroinflammation Research Laboratory, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain.|Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, UAM, Madrid, Spain.
authors.forename: Esther
authors.initials: E
authors.lastname: Parada
authors.affiliation: Molecular Neuroinflammation Research Laboratory, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain.|Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, UAM, Madrid, Spain.
authors.forename: Laura
authors.initials: L
authors.lastname: González-Lafuente
authors.affiliation: Molecular Neuroinflammation Research Laboratory, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain.|Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, UAM, Madrid, Spain.
authors.forename: Victor
authors.initials: V
authors.lastname: Farré-Alins
authors.affiliation: Departamento de Toxicología y Farmacología, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain.
authors.forename: Eva
authors.initials: E
authors.lastname: Ramos
authors.affiliation: EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, Corunna, Spain.
authors.forename: Ramón
authors.initials: R
authors.lastname: Cacabelos
authors.affiliation: Molecular Neuroinflammation Research Laboratory, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, Madrid, Spain.|Departamento de Farmacología y Terapéutica, Facultad de Medicina, Instituto Teófilo Hernando, UAM, Madrid, Spain.
authors.forename: Javier
authors.identifier: 0000-0003-4704-3019
authors.initials: J
authors.lastname: Egea
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002545:Brain Ischemia / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D008070:Lipopolysaccharides; D051379:Mice; D017628:Microglia / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009840:Oligomycins; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology; D016627:Oxidopamine; D020734:Parkinsonian Disorders / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D028321:Plant Preparations / Q000494:pharmacology*; D051381:Rats; D012402:Rotenone; D046509:Tissue Culture Techniques
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D008070:Lipopolysaccharides; D018696:Neuroprotective Agents; D009840:Oligomycins; D028321:Plant Preparations; D012402:Rotenone; C031004:oligomycin A; D016627:Oxidopamine